查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1591993

体外肺模型市场：按类型、按应用分类 - 2025-2030 年全球预测

In Vitro Lung Model Market by Type (2D Models, 3D Models), Application (3D Model Development, Drug Discovery & Toxicology, Physiological Research) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年体外肺模型市值为5.9159亿美元，预计2024年将达到6.8938亿美元，复合年增长率为16.94%，预计到2030年将达到17.7017亿美元。

市场区隔是一个利基市场，但在更广泛的生物製药和医疗保健研究行业中正在不断成长。这些模型是在细胞层面再现人类肺功能的人工系统，为药物发现、毒性测试和疾病建模提供了有价值的工具。对试管内肺模型的需求源于其透过更好地模仿人类生理反应来加速药物研究方法、减少对动物测试的依赖以及提高研究结果的准确性和适用性的潜力。应用范围涵盖药物开发、个人化医疗和安全药理学，最终用户主要是製药公司、研究机构和 CRO。

主要市场统计
基准年[2023] 5.9159 亿美元
预测年份 [2024] 68938万美元
预测年份 [2030] 1,770.17 百万美元
复合年增长率（%） 16.94%

影响市场成长的关键因素包括气喘和慢性阻塞性肺病等呼吸系统疾病盛行率的上升、组织工程的进步以及对动物试验的伦理担忧的增加。在个人化医疗和晶片器官技术等领域，在 3D 生物列印和先进生物材料等创新的推动下，忠实模拟人类肺部的机会正在增加。然而，挑战仍然存在，可能会阻碍这些模型的最佳使用，特别是通讯协定标准化、高成本以及准确再现人类肺生理学各个方面的限制。

包括将人工智慧与体外肺模型相结合以提高资料分析的准确性，开发多器官模型以提供系统见解，以及利用微流体更准确地模拟体内环境等创新研究领域正在开拓。市场偏向创新主导，竞争中等至高度，深受技术进步和合作研究的影响。为了利用新的商机，相关人员专注于提高成本效率、提高模型准确性，并与科技公司建立策略伙伴关係，以突破当前体外技术所能实现的极限。

市场动态：快速发展的体外肺部模型市场的关键市场洞察

供需的动态交互作用正在改变体外肺模型市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 对动物试验的道德替代方案的需求不断增长
    • 药物发现和开发的增加
    • 体外肺模型在疾病研究中的广泛使用
  • 市场限制因素
    • 开发和维护体外肺模型的高成本
  • 市场机会
    • 个性化医疗的趋势
    • 用于各种物质的毒性测试
  • 市场挑战
    • 与体外肺部模型相关的生理复杂性

波特五力：驾驭体外肺部模型市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解体外肺模型市场的外部影响

外部宏观环境因素在塑造体外肺模型市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解体外肺模型市场的竞争状况

对体外肺模型市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵体外肺部模型市场供应商绩效评估

FPNV定位矩阵是评估体外肺部模型市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

制定体外肺模型市场成功之路的策略分析与建议

对于旨在加强其在全球市场的影响力的公司来说，对体外肺模型市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对动物试验的道德替代方案的需求增加
      • 药物发现和开发的增加
      • 体外肺模型在疾病研究中的广泛使用
    • 抑制因素
      • 开发和维持体外肺模型的成本很高。
    • 机会
      • 个性化医疗方法的趋势
      • 用于各种物质的毒性测试
    • 任务
      • 与体外肺部模型相关的生理复杂性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章体外肺模型市场：依类型

  • 2D模型
  • 3D模型

第七章 体外肺模型市场：依应用分类

  • 3D模型开发
  • 药物发现和毒理学
  • 生理学调查
  • 干细胞研究与再生医学

第八章 北美和南美体外肺模型市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太体外肺模型市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲体外肺部模型市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AlveoliX AG
  • Brainlab AG
  • Cn Bio Innovations Limited
  • Emulate, Inc.
  • Epithelix Sarl
  • Hologic, Inc.
  • Horizon Discovery Group plc
  • Insphero AG
  • Lonza Group AG
  • Mattek Corporation by Bico Group
  • McKesson Corporation
  • Merck KGaA
  • MICA Information Systems, Inc.
  • Mimetas BV
  • PromoCell GmbH
  • STEMCELL Technologies Inc.
  • Thermo Fisher Scientific Inc
  • Tissuse GmbH
  • Varian Medical Systems, Inc
Product Code: MRR-F6513A06BD96

The In Vitro Lung Model Market was valued at USD 591.59 million in 2023, expected to reach USD 689.38 million in 2024, and is projected to grow at a CAGR of 16.94%, to USD 1,770.17 million by 2030.

The In Vitro Lung Model market represents a niche yet expanding segment within the broader biopharmaceutical and healthcare research industry. These models are engineered systems that replicate human lung function at a cellular level, providing a valuable tool for drug discovery, toxicity testing, and disease modeling. The necessity for in vitro lung models arises from their potential to expedite pharmaceutical research processes, reduce reliance on animal testing, and better mimic human physiological responses, thereby enhancing the accuracy and applicability of research findings. Applications extend across drug development, personalized medicine, and safety pharmacology, with end-users primarily including pharmaceutical companies, research institutions, and CROs.

KEY MARKET STATISTICS
Base Year [2023] USD 591.59 million
Estimated Year [2024] USD 689.38 million
Forecast Year [2030] USD 1,770.17 million
CAGR (%) 16.94%

Key factors influencing market growth include the rising prevalence of respiratory diseases like asthma and COPD, advancements in tissue engineering, and growing ethical concerns over animal testing. There are notable opportunities in segments such as personalized medicine and organ-on-chip technology, driven by innovations like 3D bioprinting and advanced biomaterials that increasingly simulate human lungs with high fidelity. However, challenges remain, particularly in standardization of protocols, high costs, and limitations in accurately replicating all facets of human lung physiology which could restrain optimal use of these models.

Innovative research areas ripe for exploration include the integration of artificial intelligence with in vitro lung models to enhance data analysis accuracy, development of multi-organ models that provide systemic insights, and the utilization of microfluidics to simulate in vivo environments more accurately. The market leans towards being innovation-driven with a moderate-to-high degree of competition, largely influenced by technological advancements and collaborations. To capitalize on emerging opportunities, stakeholders must focus on increasing cost-effectiveness, improving model accuracy, and forging strategic partnerships with technology firms to push the boundaries of what's achievable with current in vitro technologies.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving In Vitro Lung Model Market

The In Vitro Lung Model Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing demand for ethical alternatives to animal testing
    • Increase in drug discovery and development
    • Extensive use of in-viro lung model in disease research
  • Market Restraints
    • High cost of development and maintainence of in-vitro lung model
  • Market Opportunities
    • Inclination toward personalized medicine approach
    • Utilization for toxicity testing of various substances
  • Market Challenges
    • Physiological complexity associated with in-vitro lung model

Porter's Five Forces: A Strategic Tool for Navigating the In Vitro Lung Model Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the In Vitro Lung Model Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the In Vitro Lung Model Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the In Vitro Lung Model Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the In Vitro Lung Model Market

A detailed market share analysis in the In Vitro Lung Model Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the In Vitro Lung Model Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the In Vitro Lung Model Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the In Vitro Lung Model Market

A strategic analysis of the In Vitro Lung Model Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the In Vitro Lung Model Market, highlighting leading vendors and their innovative profiles. These include AlveoliX AG, Brainlab AG, Cn Bio Innovations Limited, Emulate, Inc., Epithelix Sarl, Hologic, Inc., Horizon Discovery Group plc, Insphero AG, Lonza Group AG, Mattek Corporation by Bico Group, McKesson Corporation, Merck KGaA, MICA Information Systems, Inc., Mimetas B.V., PromoCell GmbH, STEMCELL Technologies Inc., Thermo Fisher Scientific Inc, Tissuse GmbH, and Varian Medical Systems, Inc.

Market Segmentation & Coverage

This research report categorizes the In Vitro Lung Model Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across 2D Models and 3D Models.
  • Based on Application, market is studied across 3D Model Development, Drug Discovery & Toxicology, Physiological Research, and Stem Cell Research & Regenerative Medicine.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for ethical alternatives to animal testing
      • 5.1.1.2. Increase in drug discovery and development
      • 5.1.1.3. Extensive use of in-viro lung model in disease research
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of development and maintainence of in-vitro lung model
    • 5.1.3. Opportunities
      • 5.1.3.1. Inclination toward personalized medicine approach
      • 5.1.3.2. Utilization for toxicity testing of various substances
    • 5.1.4. Challenges
      • 5.1.4.1. Physiological complexity associated with in-vitro lung model
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. In Vitro Lung Model Market, by Type

  • 6.1. Introduction
  • 6.2. 2D Models
  • 6.3. 3D Models

7. In Vitro Lung Model Market, by Application

  • 7.1. Introduction
  • 7.2. 3D Model Development
  • 7.3. Drug Discovery & Toxicology
  • 7.4. Physiological Research
  • 7.5. Stem Cell Research & Regenerative Medicine

8. Americas In Vitro Lung Model Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific In Vitro Lung Model Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa In Vitro Lung Model Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AlveoliX AG
  • 2. Brainlab AG
  • 3. Cn Bio Innovations Limited
  • 4. Emulate, Inc.
  • 5. Epithelix Sarl
  • 6. Hologic, Inc.
  • 7. Horizon Discovery Group plc
  • 8. Insphero AG
  • 9. Lonza Group AG
  • 10. Mattek Corporation by Bico Group
  • 11. McKesson Corporation
  • 12. Merck KGaA
  • 13. MICA Information Systems, Inc.
  • 14. Mimetas B.V.
  • 15. PromoCell GmbH
  • 16. STEMCELL Technologies Inc.
  • 17. Thermo Fisher Scientific Inc
  • 18. Tissuse GmbH
  • 19. Varian Medical Systems, Inc

LIST OF FIGURES

  • FIGURE 1. IN VITRO LUNG MODEL MARKET RESEARCH PROCESS
  • FIGURE 2. IN VITRO LUNG MODEL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. IN VITRO LUNG MODEL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. IN VITRO LUNG MODEL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IN VITRO LUNG MODEL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IN VITRO LUNG MODEL MARKET DYNAMICS
  • TABLE 7. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY 2D MODELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY 3D MODELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY 3D MODEL DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY DRUG DISCOVERY & TOXICOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PHYSIOLOGICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY STEM CELL RESEARCH & REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. IN VITRO LUNG MODEL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. IN VITRO LUNG MODEL MARKET, FPNV POSITIONING MATRIX, 2023